Clotri-Denk
Fungal infections
ApprovedActive
Key Facts
About Denk Pharma
Denk Pharma is a long-established, privately-held German generics and consumer health company with a 75+ year history. It has built a sustainable business model around manufacturing and marketing a broad portfolio of generic pharmaceuticals and dietary supplements, primarily targeting international markets outside Germany. The company emphasizes its German manufacturing quality as a key differentiator and is actively engaged in partnerships, such as with the International Pharmaceutical Federation (FIP), to advance global access to medicines. Its strategy combines steady revenue from established generics with growth in the wellness supplement segment.
View full company profileTherapeutic Areas
Other Fungal infections Drugs
| Drug | Company | Phase |
|---|---|---|
| Liposomal Amphotericin B | Bharat Serums & Vaccines | Commercial |
| Caspofungin | BDR Pharmaceuticals | Commercial |
| Rapid Anti-Fungal Susceptibility Test | Affinity Biosensors | Research |
| Fungal Assay Portfolio Expansion | PathoFinder | Development |
| Ibrexafungerp (Scynexis Partnership) | Ligand Pharmaceuticals | Marketed |